COMPARATIVE EFFICIENCY AND TOLERABILITY OF CURRENT THERAPIES FOR EARLY RHEUMATOID ARTHRITIS

Objective: to compare the efficiency and safety of four treatment regimens using methotrexate (MT),  leflunomide (LEF),  and a combination  of MT and glucocorticoids  (GC)  for early rheumatoid  arthritis (RA) (disease duration <2 years).Subjects and methods. 141 patients with early RA (of them t...

Full description

Saved in:
Bibliographic Details
Published inNauchno-prakticheskai͡a︡ revmatologii͡a Vol. 53; no. 2; pp. 162 - 168
Main Authors Fedorenko, E. V., Lukina, G. V., Sigidin, Ya. A., Luchikhina, E. L., Karateev, D. E.
Format Journal Article
LanguageEnglish
Published IMA PRESS LLC 29.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: to compare the efficiency and safety of four treatment regimens using methotrexate (MT),  leflunomide (LEF),  and a combination  of MT and glucocorticoids  (GC)  for early rheumatoid  arthritis (RA) (disease duration <2 years).Subjects and methods. 141 patients with early RA (of them there were 122 women; mean age 51 years; mean disease duration  7.8 months;  mean DAS28 6.0) were randomized  to 4 treatment groups: 1) MT 10–20 mg/week (n = 35); 2) MT 10–20 mg/week + oral GC equivalent to 10 mg/day of prednisolone  (n = 34); 3) MT 10–20 mg/week + oral CG + single intravenous administration of methylprednisolone (MP) 1000 mg at baseline (n = 35); 4) LEF 20 mg/day (n = 37). The patients were matched for main clinical and demographic  characteristics. The duration of treatment was 1 year. Its efficiency was evaluated according to the European  League Against Rheumatism (EULAR)  criteria.Results. 125 patients completed one-year treatment. At this time, 11.4% of the patients achieved remission (DAS28 <2.6) in the MT group, 37.5% in the MT+GC group, 29.4% in the MT+GC+MP group, and 16.2% in the LEF group. Adverse events, mainly of mild intensity, were recorded in 9 patients in each MT group. A total of 7 patients had to discontinue treatment because of its inefficiency.Conclusion. All the four therapy regimens demonstrated a significant efficiency in patients with early RA; the total remission rate was 24%. The combination  of MT and GC produced the most pronounced effect. The tolerability of treatment was good in all groups.
ISSN:1995-4484
1995-4492
DOI:10.14412/1995-4484-2015-162-168